A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage Malaria

Malaria remains a significant health problem in many tropical and sub-tropical regions. The development of vaccines against the clinically active blood-stage of infection needs to consider variability and polymorphism in target antigens, and an adjuvant system able to induce broad spectrum immunity...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Kirsty L., Pouniotis, Dodie, Hanley, Jennifer, Xiang, Sue D., Ma, Charles, Coppel, Ross L., Plebanski, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428706/
https://www.ncbi.nlm.nih.gov/pubmed/30930890
http://dx.doi.org/10.3389/fimmu.2019.00331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428706/
https://www.ncbi.nlm.nih.gov/pubmed/30930890
http://dx.doi.org/10.3389/fimmu.2019.00331

Ejemplares similares